PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Sphaeralcic acid and tomentin, anti-inflammatory compounds produced in cell suspension cultures of Sphaeralcea angustifolia.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24488717 ↗2014Reported benefit

Sphaeralcic acid and tomentin, anti-inflammatory compounds produced in cell suspension cultures of Sphaeralcea angustifolia.

MouseChemical/toxinICRMaleLocal application to the ear in the phorbol ester model; the route for the 45 mg/kg dose is not stated45 mg/kg in the carrageenan footpad model; 225 mM per ear f…

Model: Acute inflammation models: lambda-carrageenan-induced footpad oedema and phorbol ester-induced auricular oedema

At 45 mg/kg tomentin inhibited carrageenan footpad oedema by 58 per cent and sphaeralcic acid by 66 per cent; locally applied tomentin at 225 mM per ear and sphaeralcic acid at 174 mM per ear inhibited phorbol ester auricular oedema by 57 and 86 per cent respectively.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.